Guggenheim Maintains Buy Rating on Tenet Healthcare, Cuts Target to $306
Guggenheim maintained its Buy rating on Tenet Healthcare and cut its price target to $306 per share from $307.
Guggenheim maintained its Buy rating on Tenet Healthcare and cut its price target to $306 per share from $307.